about
Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive ReviewLate-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry.Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment.Incidence and description of autoimmune cytopenias during treatment with ibrutinib for chronic lymphocytic leukemia.Treatment Emergent Agranulocytosis with Skin and Gingival Lesions in a Chronic Lymphocytic Leukemia Patient: A Case ReportThe clinical development of obinutuzumab for the treatment of follicular lymphoma.Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapyRituximab-related late-onset neutropenia in patients with rheumatic diseases: successful re-challenge of the treatment.An unusual cause of severe persistent neutropenia in a child with nephrotic syndrome.A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908).Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study.Drug-Induced Neutropenia: A Focus on Rituximab-Induced Late-Onset Neutropenia.Biologics in oral medicine: principles of use and practical considerations.Rituximab biosimilars.Description of late onset neutropenia in indolent lymphoma patients treated with bendamustine plus rituximab.Late-onset neutropenia after rituximab in ANCA-associated vasculitis.Incidence of late onset neutropenia associated with rituximab use in B cell lymphoma patients undergoing autologous stem cell transplantation.Clinical characteristics of adverse events associated with therapeutic monoclonal antibodies in Korea.Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses.Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center.Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases.Incidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximab
P2860
Q26773178-32EFB832-2F79-4D4C-9903-3A8AD63F95C8Q31012265-EBD74D90-1CC0-468A-B40F-3989F785D690Q33395141-B7E1DBC4-B9DC-4529-85E9-54A17B668DE5Q33426511-429FDAF6-855A-4950-A70E-44FC310E56F2Q33437143-336B64F0-CA05-4524-923F-3E98913538B5Q33565265-D9E2108A-F7DE-4F90-A3E6-23297F05A9EBQ35052000-9B068391-FFCF-4340-8F94-375BADAB8502Q35531665-1318DBDC-8B4B-4CBE-92DF-CFB43B0455CEQ36704943-2BBBCC44-C4CB-44D6-9E95-F7C0B32B800DQ36725445-4F37B9A0-F5B2-4827-8278-CE96B971D28EQ36975931-61B380BD-21B0-4626-932B-28AB882637DFQ37462856-7980AC57-ABFE-48A6-93F5-1EB32FBD7077Q37993932-282652BD-3973-4882-B92F-743993B2F9FEQ38100232-4D93FCCD-DD1B-4CC5-A493-3903F64494D5Q38689784-D33A3BAD-B666-4BB5-BC03-DA89B557D5A6Q39944154-D5608308-5830-40F3-B060-36F4D09E6340Q40272339-D6F17492-9118-46B6-B1BA-7A8A59E92F85Q40471375-21F4E617-89A9-43E3-924E-C4D405096EE3Q42908395-185E5819-5F33-4A22-9B86-4EF9D8F29851Q47581564-E9649EC1-B0C7-4743-809E-DED77F423F33Q49375952-968DB439-009F-432C-AF2D-2FE4D14A6796Q55265285-A642B00E-060E-42D0-AE83-38F37A486CEFQ57903178-111C72CE-CFEB-4C51-A391-71DDEA0F2BBB
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rituximab-associated neutropenia.
@en
Rituximab-associated neutropenia.
@nl
type
label
Rituximab-associated neutropenia.
@en
Rituximab-associated neutropenia.
@nl
prefLabel
Rituximab-associated neutropenia.
@en
Rituximab-associated neutropenia.
@nl
P2093
P1476
Rituximab-associated neutropenia.
@en
P2093
Kieron Dunleavy
Wyndham H Wilson
P304
P356
10.1053/J.SEMINHEMATOL.2010.01.009
P577
2010-04-01T00:00:00Z